Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

DCSPKA YOU ALSO SAID



dcspka Sunday, 04/13/14 09:23:55 PM
Re: dcspka post# 20732
Post # of 20749
William Gartner sold Phoenix-based Provista Life Sciences LLC’s breast and lung cancer testing technologies to a new company called Provista Diagnostics Inc., which he intends to take public by the middle of next year."

I'd say that qualifies as leaving on your own terms, as opposed to being dumped as Goldseeker claims.

Wolf Says

Here is a link to the two Clinical studies by Provista DX...

1 Recruiting Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification
Condition: Breast Cancer
Intervention:
2 Not yet recruiting Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol
Condition: Breast Cancer
Intervention:


http://www.clinicaltrials.gov/ct2/results?term=Provista+Diagnostics&Search=Search